Metagenomi, Inc. Common Stock Capital Reinvestment Ratio
Metagenomi, Inc. Common Stock capital reinvestment ratio. Metagenomi, Inc. Common Stock (MGX) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($67.73 Million) in capital expenditures ($3.51 Million). Check Metagenomi, Inc. Common Stock (MGX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Metagenomi, Inc. Common Stock (2021–2022)
Capital reinvestment ratio of Metagenomi, Inc. Common Stock from 2021 to 2022. This chart tracks Metagenomi, Inc. Common Stock's Capital Reinvestment Ratio across 2 annual periods. Also explore how fast is Metagenomi, Inc. Common Stock growing its equity to track the company's year-over-year net asset growth rate.
Metagenomi, Inc. Common Stock Capital Reinvestment Ratio by Year (2021–2022)
Metagenomi, Inc. Common Stock capital reinvestment ratio by year from 2021 to 2022. For the full cash flow conversion analysis, see Metagenomi, Inc. Common Stock operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.47x | $29.72 Million | $13.98 Million | ▲ +292.9% |
| 2021 | 0.12x | $24.26 Million | $2.90 Million | — |